These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 8895147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A.
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
    Patrignani P, Filabozzi P, Catella F, Pugliese F, Patrono C.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C, Broggini M, Castelli MG, Cozzi E, Castagnoli MN, Donelli MG, Garattini S, Giavazzi R, Fanelli R.
    Cancer Res; 1987 Feb 15; 47(4):988-91. PubMed ID: 3100032
    [Abstract] [Full Text] [Related]

  • 12. Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments.
    Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L.
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb 15; 60(2):87-93. PubMed ID: 10328327
    [Abstract] [Full Text] [Related]

  • 13. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C.
    J Lab Clin Med; 1989 May 15; 113(5):549-60. PubMed ID: 2541212
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclo-oxygenase and thromboxane synthetase inhibitors on right atrial prostaglandins.
    Madan ZM, Sainani GS.
    J Assoc Physicians India; 2000 Jun 15; 48(6):581-3. PubMed ID: 11273534
    [Abstract] [Full Text] [Related]

  • 15. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G, Imberti L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T.
    J Clin Invest; 1985 Jan 15; 75(1):94-101. PubMed ID: 4038407
    [Abstract] [Full Text] [Related]

  • 16. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS, Jones SL, Barrow SE, Stratton PD, Alessandrini P, De Cosmo S, Ritter JM, Viberti GC.
    J Lab Clin Med; 1993 Mar 15; 121(3):415-23. PubMed ID: 8445289
    [Abstract] [Full Text] [Related]

  • 17. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF, Greco DS, Behrend EN, Fettman MJ, Mani I, Getzy DM, Reinhart GA.
    Am J Vet Res; 1996 Jun 15; 57(6):948-56. PubMed ID: 8725828
    [Abstract] [Full Text] [Related]

  • 18. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov 15; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 19. A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy.
    Masumura H, Kunitada S, Irie K, Ashida S, Abe Y.
    Eur J Pharmacol; 1992 Jan 14; 210(2):163-72. PubMed ID: 1350991
    [Abstract] [Full Text] [Related]

  • 20. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM, Moore JN, Hardee GE.
    Res Vet Sci; 1986 Mar 14; 40(2):152-6. PubMed ID: 3517992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.